Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay

JAMA Dermatol. 2022 Jun 1;158(6):704-705. doi: 10.1001/jamadermatol.2022.1399.

Authors

Julia S Lehman¹, Donna A Culton², Alina G Bridges³

Affiliations

¹ Mayo Clinic Immunodermatology Laboratory, Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
² University of North Carolina Dermatology Clinical Immunofluorescence Laboratory, Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill.
³ DermPath Diagnostics, Cincinnati, Ohio.

PMID: 35544127
DOI: 10.1001/jamadermatol.2022.1399

No abstract available

Publication types

Comment

MeSH terms

Administration, Cutaneous
Fluorescent Antibody Technique, Direct
Humans
Skin*